DUBLIN – With their share of a $1 million prize from the IPF Catalyst Challenge earlier this year, health software company patientMpower has developed a digital platform for monitoring lung transplant patients.
The platform, patientMpower for Lung Transplant, allows health clinicians to track the lung function and oxygen saturation of their transplant patients remotely in real-time using integrated monitors like spirometers and oximeters.
“This platform will help patients better self-manage their care at home,” said Eamonn Costello, CEO of patientMpower. “Our clinical trials are showing that doctors are seeing their patients less frequently in the hospital.”
Earlier this year, patientMpower was one of three winners of the IPF Catalyst Challenge, an award given to projects focused on improving the quality of life for idiopathic pulmonary fibrosis (IPF) patients and their caregivers.
Costello said the company worked with specialists and patients to build a solution that is tailored to the complex needs of patients who have received a lung transplant. The resulting solution is mobile, enabling patients to keep track of everything relating to their health after a transplant and share this information with their health care team in real time. It allows patients to track and share biomarkers like temperature, medication use, breathlessness and activity, as well as set medication reminders and receive air quality and weather alerts.
Costello said developing a platform for lung transplant was a natural progression for the company because some patients with IPF end up receiving a lung transplant as their disease progresses. patientMpower has already developed an app for IPF patients, and offers solutions for kidney transplant patients and those managing hemodialysis.
Looking forward, Costello said patientMpower plans to publish results of a recent clinical trial of the platform and continue to work on a new app for caregivers.
“The digitization of health care is opening up so many possibilities,” he said. “Just five years ago it would have been too expensive to have a spirometer in the home but today people have it. Now we have to move beyond just collecting the data and start generating insights—that’s the direction we’re moving in.”